mRNA |
MS-275 |
CTRPv2 |
pan-cancer |
AAC |
-0.091 |
0.007 |
mRNA |
BRD-K41597374 |
CTRPv2 |
pan-cancer |
AAC |
-0.098 |
0.008 |
mRNA |
BRD-K27188169:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
0.008 |
mRNA |
BRD-K55116708 |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.008 |
mRNA |
alisertib:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.097 |
0.008 |
mRNA |
PD-0325901 |
gCSI |
pan-cancer |
AAC |
0.15 |
0.008 |
mRNA |
tivantinib |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.008 |
mRNA |
KX2-391 |
CTRPv2 |
pan-cancer |
AAC |
-0.088 |
0.008 |
mRNA |
TAE684 |
CTRPv2 |
pan-cancer |
AAC |
-0.097 |
0.009 |
mRNA |
etoposide |
CTRPv2 |
pan-cancer |
AAC |
-0.081 |
0.009 |